UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including
area code: (
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
| |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
| |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
| |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class: | Trading Symbol(s): | Name of each exchange on which registered: | ||
The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 | Other Events. |
Phio Pharmaceuticals Corp. (the “Company”) is aware of reports indicating the closure of Silicon Valley Bank (“SVB”) and the appointment of the Federal Deposit Insurance Corporation as receiver. The Company confirmed today that it does not hold cash deposits or securities at Silicon Valley Bank, and therefore has no financial exposure in connection with Silicon Valley Bank’s closure.
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PHIO PHARMACEUTICALS CORP. | |||||
Date: March 10, 2023 | By: | /s/ Robert Bitterman | |||
Name: Robert Bitterman Title: President and Chief Executive Officer |
3 |
Cover |
Mar. 10, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Mar. 10, 2023 |
Entity File Number | 001-36304 |
Entity Registrant Name | PHIO PHARMACEUTICALS CORP. |
Entity Central Index Key | 0001533040 |
Entity Tax Identification Number | 45-3215903 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 257 Simarano Drive |
Entity Address, Address Line Two | Suite 101 |
Entity Address, City or Town | Marlborough |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 01752 |
City Area Code | 508 |
Local Phone Number | 767-3861 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | PHIO |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
-8?2
M0$3;8T.P6BP^0"X99K>]9!:G
FPW'YH!Q$'@-,0A\.B,#!H_R2BDP\HK85Y(^L;2+ZPA=%@.+0^*"^40B,
MH2),%YTC7[=V@WM';?&-^^7>PVJW_ ]02P,$% @ 3(EJ5JXK/U
YH&9.1^0F_,!=9'>5+SD)]P9&&[6JM%OI=><&BF\-Y_VBB&G$7WH
MY%4@U8-^FHI'(^"=F&'>8H:S2.$&VXH&LOR".-J5'N0WF.LEGMM; 35(5V>\
MQ.3P%6'XI.$+]:J3&S+&EJL)=,TW@9WEN[]<7+^?I%E1@8CBI3'+_I
MC:64&I4/VH?KJ;0'^T>I5RIU+ERIJXRYQ'Y3M:\[:OGJNOWTK:U^I&HO<+=E
M!=^RUB9)-'6@K*>U/NPA"M\ZVE[%?@=+G:GTR%MZ$)NH,_( "+&>D(05^TL1
MD,$_=DT1;"
S,58(@,%)!*J;CJA>T@Y$/WX 3(MONU?!FH0
M<_GVOVOS=RL)=OUCX#SYM8E"=%#/&.(+)I]QGE1U=+O'@S95,3^8@!U/P(!+
MI2!%'N0U:JA(P4R#%%J081"V]_?8)-$->OE#\GY,C>M+, A;>![$TPB33D5\
M,K0\N>A\=]